EOC

Dime Sponsors Economic Opportunity Council on Long Island

Retrieved on: 
Thursday, April 4, 2024

HAUPPAUGE, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced that it will sponsor the Economic Opportunity Council (EOC) of Suffolk County.

Key Points: 
  • HAUPPAUGE, N.Y., April 04, 2024 (GLOBE NEWSWIRE) -- Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent company of Dime Community Bank (the “Bank”) announced that it will sponsor the Economic Opportunity Council (EOC) of Suffolk County.
  • The EOC supports homeless prevention and family development on Long Island.

Verizon Frontline delivers critical connectivity during South Carolina earthquake exercise

Retrieved on: 
Wednesday, March 20, 2024

COLUMBIA, S.C., March 20, 2024 (GLOBE NEWSWIRE) -- The Verizon Frontline Crisis Response Team recently deployed to help provide the South Carolina Emergency Management Division (SCEMD) and multiple other public safety agencies participating in a statewide earthquake response exercise with mission-critical communications capabilities.

Key Points: 
  • COLUMBIA, S.C., March 20, 2024 (GLOBE NEWSWIRE) -- The Verizon Frontline Crisis Response Team recently deployed to help provide the South Carolina Emergency Management Division (SCEMD) and multiple other public safety agencies participating in a statewide earthquake response exercise with mission-critical communications capabilities.
  • The Verizon Frontline solutions delivered by the Verizon Frontline Crisis Response Team, including the SPOTs, helped enable first responders at training sites across the state to communicate with each other and the EOC in Columbia during a simulated natural disaster scenario during which a 7.1 magnitude earthquake severely disrupted regular network connectivity.
  • To help strengthen capabilities when responding to events such as an earthquake, South Carolina routinely conducts in-depth training exercises designed to simulate real-world emergency response scenarios.
  • Verizon Frontline Crisis Response Team members set up portable cell sites, Wi-Fi hotspots, charging stations and other Verizon Frontline devices and solutions that enable communications and/or boost network performance.

Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer

Retrieved on: 
Saturday, March 16, 2024

BURLINGTON, N.C., March 16, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the 2024 SGO Annual Meeting on Women's Cancer. The studies demonstrate the value of biomarker testing in closing testing gaps and guiding targeted therapies for patients with epithelial ovarian cancer (EOC).

Key Points: 
  • The studies demonstrate the value of biomarker testing in closing testing gaps and guiding targeted therapies for patients with epithelial ovarian cancer (EOC).
  • Labcorp researchers conducted two studies to generate further evidence of the value of comprehensive genomic profiling to drive guideline-compliant testing that enables increased patient access to targeted therapies for improved outcomes.
  • When combined, the results of BRCA and HRD testing can determine which patients are most likely to benefit from treatment with poly-ADP ribose polymerase (PARP) inhibitors.
  • "This research emphasizes the power of comprehensive biomarker testing in advancing the treatment of ovarian cancer.

 Debiopharm Launches Expansion of WEE1 Inhibitor Monotherapy Research in Gynecological Cancers and Other Biomarker-driven Solid Tumors

Retrieved on: 
Thursday, March 7, 2024

The expansion of this Phase 1 study, NCT05109975 , is to characterize the safety, tolerability, and initial signs of antitumor activity of Debio 0123 when administered as monotherapy.

Key Points: 
  • The expansion of this Phase 1 study, NCT05109975 , is to characterize the safety, tolerability, and initial signs of antitumor activity of Debio 0123 when administered as monotherapy.
  • Two out of the three expansion arms of the study will be using biomarkers to pre-select patients with different solid tumors while the third arm will be treating patients with recurrent serous endometrial carcinoma.
  • Maximizing efficacy, while preserving safety are key elements that Debiopharm is eager to assess throughout the clinical development of Debio 0123.
  • With the successful realization of these requirements, Debio 0123 could become the first choice WEE1 inhibitor.

EnGenius Releases New Broadband Outdoor Wireless Solutions to Empower Industrial and Smart City Applications

Retrieved on: 
Thursday, March 7, 2024

COSTA MESA, Calif. , March 7, 2024 /PRNewswire/ -- EnGenius Technologies Inc., a pioneer in innovative connectivity solutions, has launched the new Broadband Outdoor EOC655 series, with an efficient network management system called SkyPoint. This series provides integrated Point-to-Point and Point-to-Multipoint connectivity and is ideal for various sectors, including smart cities, remote industrial control, and public safety. With dual 5 GHz radios, it is well-suited for dense radio frequency (RF) environments and offers secure and reliable broadband for last-mile and backhaul applications. The EOC series also features a mobile app, making it easy for wireless technicians and installers to deploy and use. It is designed to meet the evolving demands of dynamic industries and offers enhanced efficiency and superior functionality.

Key Points: 
  • EnGenius' EOC series is transforming connectivity in smart cities and industrial environments with advanced Point-to-Point and Point-to-Multipoint solutions.
  • COSTA MESA, Calif. , March 7, 2024 /PRNewswire/ -- EnGenius Technologies Inc., a pioneer in innovative connectivity solutions, has launched the new Broadband Outdoor EOC655 series, with an efficient network management system called SkyPoint.
  • With dual 5 GHz radios, it is well-suited for dense radio frequency (RF) environments and offers secure and reliable broadband for last-mile and backhaul applications.
  • The EOC series also features a mobile app, making it easy for wireless technicians and installers to deploy and use.

Nuvve Wins $16M Project for Fresno Economic Opportunities Commission's 50-Shuttle Fleet

Retrieved on: 
Tuesday, January 23, 2024

SAN DIEGO and FRESNO, Calif., Jan. 23, 2024 /PRNewswire/ -- Nuvve Holding Corp. (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, today was selected and approved by the Board of the Fresno Economic Opportunities Commission (Fresno EOC) to implement its turnkey fleet electrification program for Fresno EOC's 50-shuttle fleet. Nuvve assisted Fresno EOC, one of the largest nonprofit community action agencies in the U.S., in securing grant funding through the Carl Moyer Memorial Air Quality Standards Attainment Program ("Carl Moyer Program") and Pacific Gas & Electric ("PG&E"). This groundbreaking initiative underscores Fresno EOC's commitment to sustainable transportation and marks a significant step towards reducing the city's carbon footprint.

Key Points: 
  • (Nasdaq: NVVE), a global technology leader accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) platform, today was selected and approved by the Board of the Fresno Economic Opportunities Commission (Fresno EOC) to implement its turnkey fleet electrification program for Fresno EOC's 50-shuttle fleet.
  • Nuvve has taken the lead in the Fresno EOC Fleet Electrification Project, with a vision to create a sustainable and thriving community.
  • The project is driven by a commitment to empowering the local workforce, by providing opportunities for workforce development and fostering economic growth in Fresno.
  • By working together, Nuvve and the Fresno community are paving the way for excellence in fleet electrification, while enhancing local skill sets and economic prosperity.

Messagepoint Healthcare Touchpoint Exchange Wins 2024 BIG Innovation Award

Retrieved on: 
Wednesday, January 10, 2024

Messagepoint announced it has been named a winner in the 2024 BIG Innovation Awards presented by the Business Intelligence Group in the Software category for its Healthcare Touchpoint Exchange , a purpose-built SaaS solution that enables Medicare Advantage Organizations (MAOs) to dramatically reduce the workload, timelines and costs associated with health plan communications and materials preparation.

Key Points: 
  • Messagepoint announced it has been named a winner in the 2024 BIG Innovation Awards presented by the Business Intelligence Group in the Software category for its Healthcare Touchpoint Exchange , a purpose-built SaaS solution that enables Medicare Advantage Organizations (MAOs) to dramatically reduce the workload, timelines and costs associated with health plan communications and materials preparation.
  • “We are pleased that Messagepoint’s Healthcare Touchpoint Exchange has won a BIG Innovation Award for providing critical innovation that enables MAOs to achieve accuracy and compliance, efficiency and economies of scale across all member communications.”
    Messagepoint’s Healthcare Touchpoint Exchange is a game-changing solution designed to support MAOs in preparing plan communications and materials for the Annual Enrollment Period (AEP).
  • “Innovation is driving our society,” said Maria Jimenez, chief nominations officer of the Business Intelligence Group.
  • “We are thrilled to be honoring Messagepoint as they are leading by example and improving the lives of so many.”
    Organizations from across the globe submitted their recent innovations for consideration in the BIG Innovation Awards.

RemeGen's RC88 Obtained FDA Fast Track Designation, Heralds New Hope for Ovarian Cancer Patients

Retrieved on: 
Friday, January 12, 2024

This marks another significant development following the FDA's approval to RC88's international multicenter Phase II clinical trials last month.

Key Points: 
  • This marks another significant development following the FDA's approval to RC88's international multicenter Phase II clinical trials last month.
  • RC88 consists of a recombinant humanized anti-MSLN monoclonal antibody linked to the microtubule inhibitor monomethyl auristatin E (MMAE), which acts as a microtubule inhibitor.
  • The later the stage and the more aggressive the ovarian cancer, the higher the expression rate of MSLN, and current treatment options are limited.
  • Moving forward, RemeGen will continue to accelerate the development of its ADC products, with the aim of bringing more and better solutions to patients globally."

Mach Natural Resources Completes the Acquisition of Paloma Anadarko Basin Assets

Retrieved on: 
Friday, December 29, 2023

Mach Natural Resources LP (NYSE: MNR) (“Mach” or the “Company”) today announced that it has closed the acquisition (the “Acquisition”) of certain interests in oil and gas properties, rights and related assets located in certain counties in Oklahoma from Paloma Partners IV, LLC, a privately-held Delaware limited liability company backed by EnCap Investments L.P., and its affiliated companies (the “Sellers”).

Key Points: 
  • Mach Natural Resources LP (NYSE: MNR) (“Mach” or the “Company”) today announced that it has closed the acquisition (the “Acquisition”) of certain interests in oil and gas properties, rights and related assets located in certain counties in Oklahoma from Paloma Partners IV, LLC, a privately-held Delaware limited liability company backed by EnCap Investments L.P., and its affiliated companies (the “Sellers”).
  • Mach also entered into a $75 million super priority revolving credit facility (the “Revolving Credit Facility”) led by MidFirst Bank.
  • In connection with closing of the Acquisition, Mach used proceeds from the Term Loan Facility and cash on hand to repay the existing amounts outstanding under the previously outstanding revolving credit agreement and such agreement was terminated.
  • As of closing of the Acquisition, the Revolving Credit Facility was undrawn.

Mach Natural Resources Adds Accretive Acquisition in Anadarko Basin

Retrieved on: 
Monday, November 13, 2023

The Acquisition is expected to close December 29, 2023, with an effective date of September 1, 2023.

Key Points: 
  • The Acquisition is expected to close December 29, 2023, with an effective date of September 1, 2023.
  • The $825mm Senior Secured Term Loan will close in conjunction with the closing of the Acquisition.
  • Kirkland & Ellis is serving as legal advisor for Mach.
  • Vinson & Elkins is serving as legal advisor and RBC Richardson Barr is serving as financial advisor for Sellers.